0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Insomnia Medication - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-29Z3105
Home | Market Reports | Health| Health Conditions| Sleep Disorders
Global Insomnia Medication Market Insights and Forecast to 2028
BUY CHAPTERS

Insomnia Medication - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-29Z3105
Report
November 2023
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insomnia Medication - Market Size

The global Insomnia Medication market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029.

Insomnia Medication -  Market

Insomnia Medication - Market

The market is mainly driven by the significant applications of Insomnia Medication in various end use industries. The expanding demands from the Adults and Kids, are propelling Insomnia Medication market. Nonbenzodiazepine Receptor Agonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzodiazepine Receptor Agonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Insomnia Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Medication covered in this report include Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc.
The global Insomnia Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals

Scope of Insomnia Medication - Market Report

Report Metric Details
Report Name Insomnia Medication - Market
Forecasted market size in 2029 US$ 3710.3 million
CAGR 3.4%
Forecasted years 2023 - 2029
Global Insomnia Medication market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Medication market, Segment by Type:
  • Nonbenzodiazepine Receptor Agonists
  • Benzodiazepine Receptor Agonists
  • The Selective Melatonin Receptor Agonist Ramelteon
  • Sedating Antidepressants
Global Insomnia Medication market, by Application
  • Adults
  • Kids
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Insomnia Medication - Market size in 2029?

Ans: The Insomnia Medication - Market size in 2029 will be US$ 3710.3 million.

What are the Application segmentation covered in the Insomnia Medication - Market report?

Ans: The Applications covered in the Insomnia Medication - Market report are Adults, Kids

What are the Type segmentation covered in the Insomnia Medication - Market report?

Ans: The Types covered in the Insomnia Medication - Market report are Nonbenzodiazepine Receptor Agonists, Benzodiazepine Receptor Agonists, The Selective Melatonin Receptor Agonist Ramelteon, Sedating Antidepressants

1 Insomnia Medication Market Overview
1.1 Insomnia Medication Product Overview
1.2 Insomnia Medication Market Segment by Type
1.2.1 Nonbenzodiazepine Receptor Agonists
1.2.2 Benzodiazepine Receptor Agonists
1.2.3 The Selective Melatonin Receptor Agonist Ramelteon
1.2.4 Sedating Antidepressants
1.3 Global Insomnia Medication Market Size by Type
1.3.1 Global Insomnia Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Insomnia Medication Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insomnia Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insomnia Medication Sales Breakdown by Type (2018-2023)
2 Global Insomnia Medication Market Competition by Company
2.1 Global Top Players by Insomnia Medication Sales (2018-2023)
2.2 Global Top Players by Insomnia Medication Revenue (2018-2023)
2.3 Global Top Players by Insomnia Medication Price (2018-2023)
2.4 Global Top Manufacturers Insomnia Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insomnia Medication Market Competitive Situation and Trends
2.5.1 Insomnia Medication Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insomnia Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Insomnia Medication Market
2.8 Key Manufacturers Insomnia Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insomnia Medication Status and Outlook by Region
3.1 Global Insomnia Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insomnia Medication Historic Market Size by Region
3.2.1 Global Insomnia Medication Sales in Volume by Region (2018-2023)
3.2.2 Global Insomnia Medication Sales in Value by Region (2018-2023)
3.2.3 Global Insomnia Medication Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insomnia Medication Forecasted Market Size by Region
3.3.1 Global Insomnia Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Insomnia Medication Sales in Value by Region (2024-2029)
3.3.3 Global Insomnia Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insomnia Medication by Application
4.1 Insomnia Medication Market Segment by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Insomnia Medication Market Size by Application
4.2.1 Global Insomnia Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Insomnia Medication Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insomnia Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insomnia Medication Sales Breakdown by Application (2018-2023)
5 North America Insomnia Medication by Country
5.1 North America Insomnia Medication Historic Market Size by Country
5.1.1 North America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insomnia Medication Sales in Volume by Country (2018-2023)
5.1.3 North America Insomnia Medication Sales in Value by Country (2018-2023)
5.2 North America Insomnia Medication Forecasted Market Size by Country
5.2.1 North America Insomnia Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Insomnia Medication Sales in Value by Country (2024-2029)
6 Europe Insomnia Medication by Country
6.1 Europe Insomnia Medication Historic Market Size by Country
6.1.1 Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insomnia Medication Sales in Volume by Country (2018-2023)
6.1.3 Europe Insomnia Medication Sales in Value by Country (2018-2023)
6.2 Europe Insomnia Medication Forecasted Market Size by Country
6.2.1 Europe Insomnia Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Insomnia Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Insomnia Medication by Region
7.1 Asia-Pacific Insomnia Medication Historic Market Size by Region
7.1.1 Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insomnia Medication Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insomnia Medication Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insomnia Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Insomnia Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insomnia Medication Sales in Value by Region (2024-2029)
8 Latin America Insomnia Medication by Country
8.1 Latin America Insomnia Medication Historic Market Size by Country
8.1.1 Latin America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insomnia Medication Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insomnia Medication Sales in Value by Country (2018-2023)
8.2 Latin America Insomnia Medication Forecasted Market Size by Country
8.2.1 Latin America Insomnia Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insomnia Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Insomnia Medication by Country
9.1 Middle East and Africa Insomnia Medication Historic Market Size by Country
9.1.1 Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insomnia Medication Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insomnia Medication Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insomnia Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Insomnia Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insomnia Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eisai
10.1.1 Eisai Company Information
10.1.2 Eisai Introduction and Business Overview
10.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eisai Insomnia Medication Products Offered
10.1.5 Eisai Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Insomnia Medication Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Insomnia Medication Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Insomnia Medication Products Offered
10.4.5 Sanofi Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda Insomnia Medication Products Offered
10.5.5 Takeda Recent Development
10.6 Vanda Pharmaceuticals
10.6.1 Vanda Pharmaceuticals Company Information
10.6.2 Vanda Pharmaceuticals Introduction and Business Overview
10.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
10.6.5 Vanda Pharmaceuticals Recent Development
10.7 Astellas
10.7.1 Astellas Company Information
10.7.2 Astellas Introduction and Business Overview
10.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Astellas Insomnia Medication Products Offered
10.7.5 Astellas Recent Development
10.8 Dainippon Sumitomo
10.8.1 Dainippon Sumitomo Company Information
10.8.2 Dainippon Sumitomo Introduction and Business Overview
10.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
10.8.5 Dainippon Sumitomo Recent Development
10.9 ECR Pharmaceuticals (Valeant)
10.9.1 ECR Pharmaceuticals (Valeant) Company Information
10.9.2 ECR Pharmaceuticals (Valeant) Introduction and Business Overview
10.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
10.9.5 ECR Pharmaceuticals (Valeant) Recent Development
10.10 Flynn Pharma
10.10.1 Flynn Pharma Company Information
10.10.2 Flynn Pharma Introduction and Business Overview
10.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Flynn Pharma Insomnia Medication Products Offered
10.10.5 Flynn Pharma Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Johnson & Johnson Insomnia Medication Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Meda
10.12.1 Meda Company Information
10.12.2 Meda Introduction and Business Overview
10.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Meda Insomnia Medication Products Offered
10.12.5 Meda Recent Development
10.13 Somnus Therapeutics
10.13.1 Somnus Therapeutics Company Information
10.13.2 Somnus Therapeutics Introduction and Business Overview
10.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Somnus Therapeutics Insomnia Medication Products Offered
10.13.5 Somnus Therapeutics Recent Development
10.14 Purdue Pharma
10.14.1 Purdue Pharma Company Information
10.14.2 Purdue Pharma Introduction and Business Overview
10.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Purdue Pharma Insomnia Medication Products Offered
10.14.5 Purdue Pharma Recent Development
10.15 Neurim
10.15.1 Neurim Company Information
10.15.2 Neurim Introduction and Business Overview
10.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Neurim Insomnia Medication Products Offered
10.15.5 Neurim Recent Development
10.16 Minerva Neurosciences
10.16.1 Minerva Neurosciences Company Information
10.16.2 Minerva Neurosciences Introduction and Business Overview
10.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Minerva Neurosciences Insomnia Medication Products Offered
10.16.5 Minerva Neurosciences Recent Development
10.17 Pernix Therapeutics
10.17.1 Pernix Therapeutics Company Information
10.17.2 Pernix Therapeutics Introduction and Business Overview
10.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Pernix Therapeutics Insomnia Medication Products Offered
10.17.5 Pernix Therapeutics Recent Development
10.18 SkyePharma
10.18.1 SkyePharma Company Information
10.18.2 SkyePharma Introduction and Business Overview
10.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.18.4 SkyePharma Insomnia Medication Products Offered
10.18.5 SkyePharma Recent Development
10.19 Paratek Pharmaceuticals
10.19.1 Paratek Pharmaceuticals Company Information
10.19.2 Paratek Pharmaceuticals Introduction and Business Overview
10.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Paratek Pharmaceuticals Insomnia Medication Products Offered
10.19.5 Paratek Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insomnia Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insomnia Medication Industrial Chain Analysis
11.4 Insomnia Medication Market Dynamics
11.4.1 Insomnia Medication Industry Trends
11.4.2 Insomnia Medication Market Drivers
11.4.3 Insomnia Medication Market Challenges
11.4.4 Insomnia Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insomnia Medication Distributors
12.3 Insomnia Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Nonbenzodiazepine Receptor Agonists
    Table 2. Major Company of Benzodiazepine Receptor Agonists
    Table 3. Major Company of The Selective Melatonin Receptor Agonist Ramelteon
    Table 4. Major Company of Sedating Antidepressants
    Table 5. Global Insomnia Medication Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
    Table 7. Global Insomnia Medication Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Insomnia Medication Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Insomnia Medication Market Share in Value by Type (2018-2023)
    Table 10. Global Insomnia Medication Price by Type (2018-2023) & (USD/Pcs)
    Table 11. Global Insomnia Medication Sales by Type (2024-2029) & (K Pcs)
    Table 12. Global Insomnia Medication Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Insomnia Medication Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Insomnia Medication Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Insomnia Medication Price by Type (2024-2029) & (USD/Pcs)
    Table 16. North America Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
    Table 17. North America Insomnia Medication Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Insomnia Medication Sales (K Pcs) by Type (2018-2023)
    Table 19. Europe Insomnia Medication Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Insomnia Medication Sales (K Pcs) by Type (2018-2023)
    Table 21. Asia-Pacific Insomnia Medication Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Insomnia Medication Sales (K Pcs) by Type (2018-2023)
    Table 23. Latin America Insomnia Medication Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Insomnia Medication Sales (K Pcs) by Type (2018-2023)
    Table 25. Middle East and Africa Insomnia Medication Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Insomnia Medication Sales by Company (2018-2023) & (K Pcs)
    Table 27. Global Insomnia Medication Sales Share by Company (2018-2023)
    Table 28. Global Insomnia Medication Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Insomnia Medication Revenue Share by Company (2018-2023)
    Table 30. Global Market Insomnia Medication Price by Company (2018-2023) & (USD/Pcs)
    Table 31. Global Insomnia Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
    Table 34. Date of Key Manufacturers Enter into Insomnia Medication Market
    Table 35. Key Manufacturers Insomnia Medication Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Insomnia Medication Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Insomnia Medication Sales by Region (2018-2023) & (K Pcs)
    Table 39. Global Insomnia Medication Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Insomnia Medication Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Insomnia Medication Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 43. Global Insomnia Medication Sales by Region (2024-2029) & (K Pcs)
    Table 44. Global Insomnia Medication Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Insomnia Medication Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Insomnia Medication Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
    Table 48. Global Insomnia Medication Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
    Table 50. Global Insomnia Medication Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Insomnia Medication Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Insomnia Medication Price by Application (2018-2023) & (USD/Pcs)
    Table 54. Global Insomnia Medication Sales by Application (2024-2029) & (K Pcs)
    Table 55. Global Insomnia Medication Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Insomnia Medication Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Insomnia Medication Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Insomnia Medication Price by Application (2024-2029) & (USD/Pcs)
    Table 59. North America Insomnia Medication Sales by Application (2018-2023) (K Pcs)
    Table 60. North America Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Insomnia Medication Sales by Application (2018-2023) (K Pcs)
    Table 62. Europe Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Insomnia Medication Sales by Application (2018-2023) (K Pcs)
    Table 64. Asia-Pacific Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Insomnia Medication Sales by Application (2018-2023) (K Pcs)
    Table 66. Latin America Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Insomnia Medication Sales by Application (2018-2023) (K Pcs)
    Table 68. Middle East and Africa Insomnia Medication Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
    Table 70. North America Insomnia Medication Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Insomnia Medication Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Insomnia Medication Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Insomnia Medication Sales by Country (2024-2029) & (K Pcs)
    Table 74. North America Insomnia Medication Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Insomnia Medication Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Insomnia Medication Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
    Table 78. Europe Insomnia Medication Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Insomnia Medication Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Insomnia Medication Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Insomnia Medication Sales by Country (2024-2029) & (K Pcs)
    Table 82. Europe Insomnia Medication Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Insomnia Medication Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Insomnia Medication Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Insomnia Medication Sales by Region (2018-2023) & (K Pcs)
    Table 86. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Insomnia Medication Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Insomnia Medication Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Insomnia Medication Sales by Region (2024-2029) & (K Pcs)
    Table 90. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Insomnia Medication Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Insomnia Medication Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
    Table 94. Latin America Insomnia Medication Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Insomnia Medication Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Insomnia Medication Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Insomnia Medication Sales by Country (2024-2029) & (K Pcs)
    Table 98. Latin America Insomnia Medication Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Insomnia Medication Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Insomnia Medication Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
    Table 102. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Insomnia Medication Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Insomnia Medication Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Insomnia Medication Sales by Country (2024-2029) & (K Pcs)
    Table 106. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Insomnia Medication Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Insomnia Medication Sales Market Share in Value by Country (2024-2029)
    Table 109. Eisai Company Information
    Table 110. Eisai Introduction and Business Overview
    Table 111. Eisai Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 112. Eisai Insomnia Medication Product
    Table 113. Eisai Recent Development
    Table 114. Merck Company Information
    Table 115. Merck Introduction and Business Overview
    Table 116. Merck Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 117. Merck Insomnia Medication Product
    Table 118. Merck Recent Development
    Table 119. Pfizer Company Information
    Table 120. Pfizer Introduction and Business Overview
    Table 121. Pfizer Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 122. Pfizer Insomnia Medication Product
    Table 123. Pfizer Recent Development
    Table 124. Sanofi Company Information
    Table 125. Sanofi Introduction and Business Overview
    Table 126. Sanofi Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 127. Sanofi Insomnia Medication Product
    Table 128. Sanofi Recent Development
    Table 129. Takeda Company Information
    Table 130. Takeda Introduction and Business Overview
    Table 131. Takeda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 132. Takeda Insomnia Medication Product
    Table 133. Takeda Recent Development
    Table 134. Vanda Pharmaceuticals Company Information
    Table 135. Vanda Pharmaceuticals Introduction and Business Overview
    Table 136. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 137. Vanda Pharmaceuticals Insomnia Medication Product
    Table 138. Vanda Pharmaceuticals Recent Development
    Table 139. Astellas Company Information
    Table 140. Astellas Introduction and Business Overview
    Table 141. Astellas Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 142. Astellas Insomnia Medication Product
    Table 143. Astellas Recent Development
    Table 144. Dainippon Sumitomo Company Information
    Table 145. Dainippon Sumitomo Introduction and Business Overview
    Table 146. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 147. Dainippon Sumitomo Insomnia Medication Product
    Table 148. Dainippon Sumitomo Recent Development
    Table 149. ECR Pharmaceuticals (Valeant) Company Information
    Table 150. ECR Pharmaceuticals (Valeant) Introduction and Business Overview
    Table 151. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 152. ECR Pharmaceuticals (Valeant) Insomnia Medication Product
    Table 153. ECR Pharmaceuticals (Valeant) Recent Development
    Table 154. Flynn Pharma Company Information
    Table 155. Flynn Pharma Introduction and Business Overview
    Table 156. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 157. Flynn Pharma Insomnia Medication Product
    Table 158. Flynn Pharma Recent Development
    Table 159. Johnson & Johnson Company Information
    Table 160. Johnson & Johnson Introduction and Business Overview
    Table 161. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 162. Johnson & Johnson Insomnia Medication Product
    Table 163. Johnson & Johnson Recent Development
    Table 164. Meda Company Information
    Table 165. Meda Introduction and Business Overview
    Table 166. Meda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 167. Meda Insomnia Medication Product
    Table 168. Meda Recent Development
    Table 169. Somnus Therapeutics Company Information
    Table 170. Somnus Therapeutics Introduction and Business Overview
    Table 171. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 172. Somnus Therapeutics Insomnia Medication Product
    Table 173. Somnus Therapeutics Recent Development
    Table 174. Purdue Pharma Company Information
    Table 175. Purdue Pharma Introduction and Business Overview
    Table 176. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 177. Purdue Pharma Insomnia Medication Product
    Table 178. Purdue Pharma Recent Development
    Table 179. Neurim Company Information
    Table 180. Neurim Introduction and Business Overview
    Table 181. Neurim Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 182. Neurim Insomnia Medication Product
    Table 183. Neurim Recent Development
    Table 184. Minerva Neurosciences Company Information
    Table 185. Minerva Neurosciences Introduction and Business Overview
    Table 186. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 187. Minerva Neurosciences Insomnia Medication Product
    Table 188. Minerva Neurosciences Recent Development
    Table 189. Pernix Therapeutics Company Information
    Table 190. Pernix Therapeutics Introduction and Business Overview
    Table 191. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 192. Pernix Therapeutics Insomnia Medication Product
    Table 193. Pernix Therapeutics Recent Development
    Table 194. SkyePharma Company Information
    Table 195. SkyePharma Introduction and Business Overview
    Table 196. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 197. SkyePharma Insomnia Medication Product
    Table 198. SkyePharma Recent Development
    Table 199. Paratek Pharmaceuticals Company Information
    Table 200. Paratek Pharmaceuticals Introduction and Business Overview
    Table 201. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 202. Paratek Pharmaceuticals Insomnia Medication Product
    Table 203. Paratek Pharmaceuticals Recent Development
    Table 204. Key Raw Materials Lists
    Table 205. Raw Materials Key Suppliers Lists
    Table 206. Insomnia Medication Market Trends
    Table 207. Insomnia Medication Market Drivers
    Table 208. Insomnia Medication Market Challenges
    Table 209. Insomnia Medication Market Restraints
    Table 210. Insomnia Medication Distributors List
    Table 211. Insomnia Medication Downstream Customers
    Table 212. Research Programs/Design for This Report
    Table 213. Key Data Information from Secondary Sources
    Table 214. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insomnia Medication Product Picture
    Figure 2. Global Insomnia Medication Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Insomnia Medication Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Insomnia Medication Sales Status and Outlook (2018-2029) & (K Pcs)
    Figure 5. Product Picture of Nonbenzodiazepine Receptor Agonists
    Figure 6. Global Nonbenzodiazepine Receptor Agonists Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 7. Product Picture of Benzodiazepine Receptor Agonists
    Figure 8. Global Benzodiazepine Receptor Agonists Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 9. Product Picture of The Selective Melatonin Receptor Agonist Ramelteon
    Figure 10. Global The Selective Melatonin Receptor Agonist Ramelteon Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 11. Product Picture of Sedating Antidepressants
    Figure 12. Global Sedating Antidepressants Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 13. Global Insomnia Medication Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Insomnia Medication Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Insomnia Medication Sales Market Share in Volume by Type in 2022
    Figure 16. North America Insomnia Medication Sales Market Share in Value by Type in 2022
    Figure 17. Europe Insomnia Medication Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Insomnia Medication Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Insomnia Medication Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Insomnia Medication Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Insomnia Medication Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Insomnia Medication Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Revenue in 2022
    Figure 27. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Adults
    Figure 29. Global Adults Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 30. Product Picture of Kids
    Figure 31. Global Kids Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 32. Global Insomnia Medication Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Insomnia Medication Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Insomnia Medication Sales Market Share in Volume by Application in 2022
    Figure 35. North America Insomnia Medication Sales Market Share in Value by Application in 2022
    Figure 36. Europe Insomnia Medication Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Insomnia Medication Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Insomnia Medication Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Insomnia Medication Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Insomnia Medication Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Insomnia Medication Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Insomnia Medication Manufacturing Cost Structure
    Figure 45. Insomnia Medication Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS